Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neurosurgical Procedures | 45 | 2022 | 2003 | 5.460 |
Why?
|
Craniotomy | 29 | 2022 | 729 | 4.800 |
Why?
|
Pituitary Neoplasms | 28 | 2024 | 1346 | 4.600 |
Why?
|
Rhinitis | 19 | 2018 | 691 | 4.050 |
Why?
|
Brain Neoplasms | 49 | 2022 | 8860 | 3.950 |
Why?
|
Sinusitis | 19 | 2018 | 923 | 3.630 |
Why?
|
Defensive Medicine | 6 | 2017 | 48 | 3.320 |
Why?
|
Neurosurgery | 12 | 2022 | 643 | 3.020 |
Why?
|
Endoscopy | 23 | 2024 | 1784 | 2.980 |
Why?
|
Paranasal Sinuses | 9 | 2019 | 250 | 2.460 |
Why?
|
Postoperative Complications | 48 | 2022 | 15294 | 2.300 |
Why?
|
Venous Thromboembolism | 16 | 2022 | 1670 | 2.120 |
Why?
|
Spinal Diseases | 7 | 2023 | 538 | 2.110 |
Why?
|
Adenoma | 18 | 2024 | 2174 | 1.920 |
Why?
|
Malpractice | 7 | 2023 | 572 | 1.510 |
Why?
|
Glioma | 14 | 2022 | 3401 | 1.430 |
Why?
|
Granular Cell Tumor | 2 | 2019 | 51 | 1.290 |
Why?
|
Craniopharyngioma | 3 | 2021 | 281 | 1.110 |
Why?
|
Microsurgery | 5 | 2022 | 796 | 1.090 |
Why?
|
Glioblastoma | 12 | 2023 | 3481 | 1.090 |
Why?
|
Intracranial Aneurysm | 8 | 2019 | 1197 | 1.080 |
Why?
|
Nasal Cavity | 4 | 2016 | 313 | 1.070 |
Why?
|
Prolactinoma | 4 | 2023 | 113 | 1.010 |
Why?
|
ACTH-Secreting Pituitary Adenoma | 4 | 2023 | 62 | 0.980 |
Why?
|
Spinal Fusion | 12 | 2021 | 1241 | 0.960 |
Why?
|
Patient Readmission | 16 | 2020 | 3114 | 0.960 |
Why?
|
Decompressive Craniectomy | 2 | 2022 | 72 | 0.940 |
Why?
|
Nasal Obstruction | 2 | 2016 | 151 | 0.920 |
Why?
|
Quality Improvement | 19 | 2020 | 3746 | 0.910 |
Why?
|
Antibiotic Prophylaxis | 3 | 2017 | 638 | 0.890 |
Why?
|
Spinal Neoplasms | 3 | 2020 | 760 | 0.890 |
Why?
|
Spine | 9 | 2023 | 1145 | 0.890 |
Why?
|
Meningioma | 7 | 2023 | 1209 | 0.880 |
Why?
|
Skull Base Neoplasms | 5 | 2020 | 284 | 0.870 |
Why?
|
Olfaction Disorders | 2 | 2015 | 222 | 0.860 |
Why?
|
Pulmonary Embolism | 6 | 2022 | 2375 | 0.850 |
Why?
|
Insurance, Liability | 3 | 2017 | 102 | 0.850 |
Why?
|
Humans | 241 | 2024 | 744220 | 0.850 |
Why?
|
Neuroendoscopy | 4 | 2021 | 105 | 0.830 |
Why?
|
Human Growth Hormone | 2 | 2017 | 683 | 0.800 |
Why?
|
Surgical Wound Infection | 6 | 2018 | 1540 | 0.790 |
Why?
|
Hormone Replacement Therapy | 2 | 2017 | 744 | 0.780 |
Why?
|
Middle Aged | 117 | 2023 | 213367 | 0.780 |
Why?
|
Sella Turcica | 3 | 2022 | 119 | 0.770 |
Why?
|
Adult | 111 | 2023 | 214035 | 0.760 |
Why?
|
Reoperation | 13 | 2019 | 4203 | 0.750 |
Why?
|
Female | 147 | 2024 | 380197 | 0.750 |
Why?
|
Facial Pain | 2 | 2014 | 127 | 0.740 |
Why?
|
Male | 141 | 2024 | 350027 | 0.740 |
Why?
|
Central Nervous System Cysts | 2 | 2018 | 58 | 0.740 |
Why?
|
Skull | 5 | 2022 | 813 | 0.730 |
Why?
|
Cranial Nerve Neoplasms | 2 | 2018 | 129 | 0.720 |
Why?
|
Venous Thrombosis | 4 | 2022 | 1238 | 0.720 |
Why?
|
Retrospective Studies | 75 | 2024 | 77426 | 0.710 |
Why?
|
Eccrine Glands | 1 | 2020 | 45 | 0.710 |
Why?
|
Databases, Factual | 13 | 2023 | 7730 | 0.710 |
Why?
|
Meningeal Neoplasms | 6 | 2023 | 1241 | 0.700 |
Why?
|
Treatment Outcome | 60 | 2024 | 63119 | 0.690 |
Why?
|
Aged | 87 | 2023 | 163253 | 0.680 |
Why?
|
Neoplasm Recurrence, Local | 12 | 2024 | 9230 | 0.680 |
Why?
|
Cranial Irradiation | 2 | 2019 | 401 | 0.670 |
Why?
|
Skull Neoplasms | 1 | 2020 | 173 | 0.670 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 2021 | 254 | 0.660 |
Why?
|
Sweat Gland Neoplasms | 1 | 2020 | 108 | 0.640 |
Why?
|
Natural Orifice Endoscopic Surgery | 2 | 2019 | 118 | 0.640 |
Why?
|
Endovascular Procedures | 5 | 2019 | 1979 | 0.630 |
Why?
|
Postoperative Period | 9 | 2021 | 1841 | 0.620 |
Why?
|
Headache | 3 | 2018 | 1226 | 0.620 |
Why?
|
Chordoma | 2 | 2018 | 359 | 0.610 |
Why?
|
Middle Cerebral Artery | 2 | 2017 | 264 | 0.600 |
Why?
|
Quality of Life | 16 | 2023 | 12805 | 0.600 |
Why?
|
Pituitary ACTH Hypersecretion | 2 | 2021 | 176 | 0.590 |
Why?
|
Chronic Disease | 18 | 2018 | 9147 | 0.580 |
Why?
|
Sphenoid Bone | 6 | 2017 | 172 | 0.580 |
Why?
|
Radiosurgery | 5 | 2022 | 1328 | 0.570 |
Why?
|
Exercise Therapy | 1 | 2023 | 906 | 0.570 |
Why?
|
SEER Program | 3 | 2019 | 1508 | 0.570 |
Why?
|
Aged, 80 and over | 43 | 2023 | 57768 | 0.570 |
Why?
|
Sphenoid Sinus | 6 | 2018 | 100 | 0.540 |
Why?
|
Cavernous Sinus | 1 | 2017 | 125 | 0.540 |
Why?
|
Aneurysm | 1 | 2019 | 339 | 0.540 |
Why?
|
Valproic Acid | 1 | 2018 | 445 | 0.530 |
Why?
|
Nose | 4 | 2016 | 509 | 0.530 |
Why?
|
Prognosis | 26 | 2023 | 29050 | 0.530 |
Why?
|
Anticoagulants | 7 | 2022 | 4599 | 0.530 |
Why?
|
Ependyma | 1 | 2015 | 54 | 0.530 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2017 | 232 | 0.520 |
Why?
|
Radiculopathy | 2 | 2021 | 197 | 0.520 |
Why?
|
Anticonvulsants | 4 | 2020 | 1917 | 0.520 |
Why?
|
Follow-Up Studies | 27 | 2023 | 39045 | 0.500 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 2 | 2008 | 312 | 0.500 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2017 | 341 | 0.500 |
Why?
|
Surgery, Computer-Assisted | 2 | 2024 | 1018 | 0.490 |
Why?
|
Frontal Sinus | 1 | 2014 | 50 | 0.490 |
Why?
|
Pituitary Diseases | 3 | 2022 | 141 | 0.490 |
Why?
|
Carcinoma, Merkel Cell | 1 | 2018 | 300 | 0.490 |
Why?
|
Dopamine Agonists | 2 | 2023 | 355 | 0.480 |
Why?
|
Nose Neoplasms | 1 | 2016 | 246 | 0.480 |
Why?
|
Young Adult | 44 | 2023 | 56436 | 0.470 |
Why?
|
Meningitis, Bacterial | 1 | 2016 | 218 | 0.470 |
Why?
|
Subarachnoid Hemorrhage | 5 | 2023 | 1018 | 0.470 |
Why?
|
Embolization, Therapeutic | 3 | 2018 | 1392 | 0.470 |
Why?
|
Health Care Sector | 1 | 2015 | 194 | 0.460 |
Why?
|
Length of Stay | 17 | 2021 | 6308 | 0.460 |
Why?
|
Liability, Legal | 3 | 2023 | 213 | 0.440 |
Why?
|
Meningocele | 1 | 2013 | 45 | 0.440 |
Why?
|
Algorithms | 6 | 2023 | 13885 | 0.440 |
Why?
|
Skull Base | 6 | 2024 | 306 | 0.440 |
Why?
|
Hyponatremia | 1 | 2016 | 298 | 0.440 |
Why?
|
Neuronavigation | 1 | 2014 | 167 | 0.440 |
Why?
|
Muscle Relaxants, Central | 1 | 2013 | 86 | 0.430 |
Why?
|
Rare Diseases | 1 | 2017 | 553 | 0.430 |
Why?
|
Baclofen | 1 | 2013 | 129 | 0.430 |
Why?
|
Infusion Pumps, Implantable | 1 | 2013 | 156 | 0.430 |
Why?
|
Coma | 1 | 2016 | 475 | 0.420 |
Why?
|
Risk Factors | 38 | 2023 | 72280 | 0.420 |
Why?
|
Stereotaxic Techniques | 1 | 2014 | 535 | 0.410 |
Why?
|
Carcinoma, Papillary | 1 | 2017 | 783 | 0.410 |
Why?
|
Carotid Artery, Internal | 1 | 2014 | 445 | 0.410 |
Why?
|
Sarcoma, Myeloid | 1 | 2012 | 59 | 0.400 |
Why?
|
Publishing | 1 | 2019 | 833 | 0.400 |
Why?
|
Statistics as Topic | 1 | 2017 | 2374 | 0.380 |
Why?
|
Prospective Studies | 30 | 2022 | 53280 | 0.380 |
Why?
|
Paranasal Sinus Neoplasms | 3 | 2019 | 234 | 0.380 |
Why?
|
Severity of Illness Index | 8 | 2020 | 15538 | 0.380 |
Why?
|
Specialties, Surgical | 1 | 2015 | 391 | 0.370 |
Why?
|
United States | 30 | 2023 | 69867 | 0.370 |
Why?
|
Survival Rate | 11 | 2020 | 12781 | 0.370 |
Why?
|
DNA Modification Methylases | 2 | 2021 | 206 | 0.360 |
Why?
|
Third Ventricle | 2 | 2021 | 76 | 0.360 |
Why?
|
Pituitary Gland | 5 | 2023 | 665 | 0.360 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2213 | 0.360 |
Why?
|
Lumbar Vertebrae | 8 | 2021 | 1848 | 0.350 |
Why?
|
Internal Fixators | 3 | 2021 | 188 | 0.350 |
Why?
|
Diskectomy | 4 | 2021 | 206 | 0.350 |
Why?
|
Cohort Studies | 23 | 2024 | 40559 | 0.350 |
Why?
|
Randomized Controlled Trials as Topic | 6 | 2020 | 9960 | 0.350 |
Why?
|
Heparin | 1 | 2017 | 1637 | 0.350 |
Why?
|
Aneurysm, Ruptured | 4 | 2019 | 452 | 0.340 |
Why?
|
DNA Repair Enzymes | 2 | 2021 | 349 | 0.330 |
Why?
|
Sarcoma | 1 | 2020 | 1897 | 0.330 |
Why?
|
Adolescent | 40 | 2023 | 85759 | 0.330 |
Why?
|
Incidence | 16 | 2023 | 20945 | 0.330 |
Why?
|
Skin Neoplasms | 2 | 2018 | 5670 | 0.330 |
Why?
|
Patient-Centered Care | 2 | 2015 | 1438 | 0.320 |
Why?
|
Carcinoma | 1 | 2020 | 2375 | 0.320 |
Why?
|
Spinal Injuries | 2 | 2021 | 301 | 0.310 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2013 | 632 | 0.310 |
Why?
|
Periodicals as Topic | 1 | 2019 | 1432 | 0.310 |
Why?
|
Attitude of Health Personnel | 3 | 2017 | 3842 | 0.310 |
Why?
|
Multivariate Analysis | 9 | 2019 | 12244 | 0.310 |
Why?
|
Respiratory Insufficiency | 1 | 2016 | 1199 | 0.300 |
Why?
|
Logistic Models | 15 | 2022 | 13409 | 0.300 |
Why?
|
Nasal Polyps | 2 | 2016 | 360 | 0.300 |
Why?
|
Decompression, Surgical | 4 | 2020 | 594 | 0.300 |
Why?
|
Spinal Curvatures | 2 | 2019 | 66 | 0.300 |
Why?
|
Lymphoma | 1 | 2016 | 1873 | 0.300 |
Why?
|
Preoperative Care | 5 | 2021 | 2246 | 0.300 |
Why?
|
Radiotherapy, Adjuvant | 3 | 2021 | 1770 | 0.290 |
Why?
|
Fibromyalgia | 2 | 2008 | 388 | 0.290 |
Why?
|
Gastroesophageal Reflux | 1 | 2014 | 782 | 0.290 |
Why?
|
Neuroma, Acoustic | 2 | 2022 | 451 | 0.280 |
Why?
|
Central Nervous System Neoplasms | 3 | 2022 | 895 | 0.280 |
Why?
|
Kyphosis | 2 | 2021 | 237 | 0.280 |
Why?
|
Immunotherapy | 2 | 2020 | 4440 | 0.280 |
Why?
|
Mobility Limitation | 2 | 2021 | 410 | 0.280 |
Why?
|
Brain Abscess | 2 | 2018 | 118 | 0.270 |
Why?
|
Smell | 1 | 2008 | 244 | 0.270 |
Why?
|
Cerebrospinal Fluid Rhinorrhea | 2 | 2018 | 80 | 0.270 |
Why?
|
Canada | 3 | 2016 | 2065 | 0.270 |
Why?
|
Head and Neck Neoplasms | 1 | 2020 | 2732 | 0.270 |
Why?
|
Oligodendroglioma | 2 | 2020 | 279 | 0.270 |
Why?
|
Models, Neurological | 1 | 2014 | 1775 | 0.270 |
Why?
|
Hydrocephalus | 3 | 2021 | 748 | 0.260 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2015 | 1209 | 0.260 |
Why?
|
Spinal Cord Diseases | 2 | 2021 | 299 | 0.250 |
Why?
|
Steroids | 2 | 2021 | 931 | 0.250 |
Why?
|
Informed Consent | 3 | 2022 | 995 | 0.250 |
Why?
|
Predictive Value of Tests | 12 | 2021 | 15070 | 0.240 |
Why?
|
Risk | 5 | 2017 | 9685 | 0.240 |
Why?
|
Surgical Instruments | 2 | 2018 | 395 | 0.240 |
Why?
|
Spinal Stenosis | 2 | 2021 | 255 | 0.240 |
Why?
|
Stroke | 5 | 2023 | 9981 | 0.230 |
Why?
|
Delivery of Health Care | 3 | 2019 | 5319 | 0.230 |
Why?
|
Scoliosis | 2 | 2021 | 725 | 0.230 |
Why?
|
Cervical Vertebrae | 4 | 2021 | 975 | 0.230 |
Why?
|
Astrocytoma | 2 | 2021 | 789 | 0.230 |
Why?
|
Low Back Pain | 1 | 2012 | 956 | 0.230 |
Why?
|
Nervous System Diseases | 3 | 2019 | 1623 | 0.220 |
Why?
|
Kaplan-Meier Estimate | 6 | 2020 | 6535 | 0.220 |
Why?
|
Survival Analysis | 5 | 2020 | 10250 | 0.220 |
Why?
|
Internationality | 2 | 2018 | 1003 | 0.220 |
Why?
|
Registries | 11 | 2019 | 8090 | 0.220 |
Why?
|
Cerebral Angiography | 2 | 2019 | 1285 | 0.210 |
Why?
|
Cognition Disorders | 1 | 2017 | 4041 | 0.210 |
Why?
|
Age Distribution | 3 | 2017 | 2903 | 0.210 |
Why?
|
Ventriculostomy | 2 | 2021 | 136 | 0.210 |
Why?
|
Privacy | 2 | 2022 | 239 | 0.210 |
Why?
|
Anti-Bacterial Agents | 6 | 2018 | 7179 | 0.210 |
Why?
|
Self Report | 3 | 2019 | 3558 | 0.210 |
Why?
|
Postoperative Hemorrhage | 2 | 2017 | 412 | 0.210 |
Why?
|
Endarterectomy, Carotid | 2 | 2019 | 546 | 0.200 |
Why?
|
Natural Language Processing | 2 | 2020 | 1040 | 0.200 |
Why?
|
Melanoma | 2 | 2018 | 5475 | 0.190 |
Why?
|
Neoplasms | 6 | 2020 | 21672 | 0.190 |
Why?
|
Cerebral Hemorrhage, Traumatic | 1 | 2020 | 20 | 0.190 |
Why?
|
Body Constitution | 1 | 2021 | 278 | 0.190 |
Why?
|
Comorbidity | 7 | 2019 | 10387 | 0.190 |
Why?
|
Magnetic Resonance Imaging | 10 | 2021 | 35423 | 0.180 |
Why?
|
Hemangioma, Cavernous, Central Nervous System | 1 | 2020 | 56 | 0.180 |
Why?
|
Telemedicine | 3 | 2022 | 2872 | 0.180 |
Why?
|
Urinary Tract Infections | 2 | 2016 | 788 | 0.180 |
Why?
|
Tinnitus | 1 | 2022 | 195 | 0.180 |
Why?
|
Lordosis | 2 | 2020 | 84 | 0.180 |
Why?
|
Alcoholic Beverages | 1 | 2021 | 265 | 0.180 |
Why?
|
Analgesics, Opioid | 3 | 2020 | 3674 | 0.180 |
Why?
|
Research Report | 2 | 2020 | 355 | 0.170 |
Why?
|
Carcinoma, Ductal | 1 | 2020 | 101 | 0.170 |
Why?
|
Brain Mapping | 2 | 2015 | 6671 | 0.170 |
Why?
|
Cognition | 1 | 2017 | 6765 | 0.170 |
Why?
|
Titanium | 1 | 2022 | 494 | 0.170 |
Why?
|
Disease-Free Survival | 3 | 2023 | 6893 | 0.170 |
Why?
|
Odds Ratio | 6 | 2021 | 9849 | 0.170 |
Why?
|
Geographic Information Systems | 1 | 2021 | 281 | 0.170 |
Why?
|
Intracranial Hemorrhages | 4 | 2017 | 855 | 0.170 |
Why?
|
Morals | 1 | 2022 | 284 | 0.170 |
Why?
|
Time Factors | 13 | 2019 | 40063 | 0.170 |
Why?
|
Patient Discharge | 4 | 2019 | 3313 | 0.170 |
Why?
|
Ventriculoperitoneal Shunt | 1 | 2020 | 194 | 0.170 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2020 | 367 | 0.160 |
Why?
|
Epilepsy, Post-Traumatic | 1 | 2018 | 40 | 0.160 |
Why?
|
Pain Measurement | 3 | 2019 | 3419 | 0.160 |
Why?
|
Abdominal Wall | 1 | 2020 | 157 | 0.160 |
Why?
|
Somatotypes | 1 | 2018 | 41 | 0.160 |
Why?
|
Hematoma, Subdural | 1 | 2019 | 126 | 0.160 |
Why?
|
Brachial Plexus Neuritis | 1 | 2018 | 22 | 0.160 |
Why?
|
Health Status Indicators | 2 | 2016 | 969 | 0.160 |
Why?
|
Research Personnel | 1 | 2023 | 573 | 0.160 |
Why?
|
Speech | 1 | 2023 | 540 | 0.160 |
Why?
|
Spondylolisthesis | 1 | 2020 | 163 | 0.160 |
Why?
|
Angiography, Digital Subtraction | 1 | 2019 | 341 | 0.150 |
Why?
|
Tea | 1 | 2019 | 275 | 0.150 |
Why?
|
Iodide Peroxidase | 1 | 2019 | 293 | 0.150 |
Why?
|
Tranexamic Acid | 1 | 2019 | 146 | 0.150 |
Why?
|
Hematoma, Subdural, Chronic | 1 | 2018 | 90 | 0.150 |
Why?
|
Pain, Postoperative | 4 | 2020 | 1640 | 0.150 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2020 | 658 | 0.150 |
Why?
|
Chondrosarcoma | 2 | 2013 | 309 | 0.150 |
Why?
|
Brain Concussion | 2 | 2021 | 1320 | 0.150 |
Why?
|
Combined Modality Therapy | 5 | 2020 | 8628 | 0.150 |
Why?
|
Post-Exposure Prophylaxis | 1 | 2018 | 102 | 0.150 |
Why?
|
Oncolytic Viruses | 1 | 2021 | 326 | 0.150 |
Why?
|
Intermittent Pneumatic Compression Devices | 1 | 2017 | 25 | 0.150 |
Why?
|
Bone Transplantation | 1 | 2022 | 907 | 0.150 |
Why?
|
Adenoma, Oxyphilic | 1 | 2018 | 143 | 0.150 |
Why?
|
Stockings, Compression | 1 | 2017 | 37 | 0.150 |
Why?
|
Platelet Transfusion | 1 | 2020 | 314 | 0.150 |
Why?
|
Therapies, Investigational | 1 | 2018 | 112 | 0.150 |
Why?
|
Scalp | 1 | 2020 | 380 | 0.150 |
Why?
|
Antifibrinolytic Agents | 1 | 2019 | 254 | 0.150 |
Why?
|
Growth Hormone-Secreting Pituitary Adenoma | 1 | 2017 | 45 | 0.150 |
Why?
|
Pain | 2 | 2023 | 4987 | 0.150 |
Why?
|
Gonadotrophs | 1 | 2016 | 19 | 0.150 |
Why?
|
Thyroid Hormones | 1 | 2019 | 390 | 0.140 |
Why?
|
Receptor, Notch1 | 1 | 2020 | 502 | 0.140 |
Why?
|
DNA Methylation | 2 | 2021 | 4289 | 0.140 |
Why?
|
Databases, Bibliographic | 1 | 2017 | 128 | 0.140 |
Why?
|
Body Mass Index | 5 | 2021 | 12718 | 0.140 |
Why?
|
Watchful Waiting | 1 | 2021 | 491 | 0.140 |
Why?
|
Vitamin K | 1 | 2018 | 295 | 0.140 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2012 | 3523 | 0.140 |
Why?
|
Triiodothyronine | 1 | 2018 | 494 | 0.140 |
Why?
|
Netherlands | 2 | 2018 | 2170 | 0.140 |
Why?
|
Laminectomy | 2 | 2015 | 234 | 0.140 |
Why?
|
Respiratory System Agents | 1 | 2016 | 29 | 0.140 |
Why?
|
Aminolevulinic Acid | 1 | 2016 | 142 | 0.140 |
Why?
|
Illinois | 1 | 2016 | 119 | 0.140 |
Why?
|
American Civil War | 1 | 2015 | 8 | 0.130 |
Why?
|
Orthopedic Procedures | 2 | 2019 | 1288 | 0.130 |
Why?
|
Herpesvirus 1, Human | 1 | 2021 | 743 | 0.130 |
Why?
|
Oncolytic Virotherapy | 1 | 2021 | 497 | 0.130 |
Why?
|
Otolaryngology | 1 | 2022 | 645 | 0.130 |
Why?
|
Hyperprolactinemia | 1 | 2016 | 129 | 0.130 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2021 | 484 | 0.130 |
Why?
|
Verbal Behavior | 1 | 2017 | 339 | 0.130 |
Why?
|
Endocrine Surgical Procedures | 1 | 2015 | 33 | 0.130 |
Why?
|
Remission Induction | 2 | 2021 | 2389 | 0.130 |
Why?
|
Body Size | 1 | 2018 | 461 | 0.130 |
Why?
|
Dexamethasone | 2 | 2023 | 1948 | 0.130 |
Why?
|
Psychosurgery | 1 | 2015 | 87 | 0.130 |
Why?
|
United States Food and Drug Administration | 1 | 2023 | 1583 | 0.130 |
Why?
|
Radiology | 2 | 2020 | 2099 | 0.130 |
Why?
|
Meningitis, Pneumococcal | 1 | 2015 | 42 | 0.130 |
Why?
|
Ki-67 Antigen | 1 | 2017 | 644 | 0.130 |
Why?
|
Tumor Burden | 2 | 2018 | 1914 | 0.130 |
Why?
|
Sex Distribution | 2 | 2017 | 2297 | 0.130 |
Why?
|
Postoperative Care | 2 | 2018 | 1485 | 0.130 |
Why?
|
Hearing Loss | 1 | 2022 | 765 | 0.130 |
Why?
|
Texas | 1 | 2016 | 392 | 0.130 |
Why?
|
ABO Blood-Group System | 1 | 2017 | 367 | 0.130 |
Why?
|
Spinal Fractures | 1 | 2021 | 696 | 0.130 |
Why?
|
Coffee | 1 | 2019 | 578 | 0.120 |
Why?
|
Data Mining | 1 | 2020 | 537 | 0.120 |
Why?
|
Meningoencephalitis | 1 | 2015 | 78 | 0.120 |
Why?
|
Penicillins | 1 | 2017 | 380 | 0.120 |
Why?
|
Recurrence | 5 | 2022 | 8343 | 0.120 |
Why?
|
Famous Persons | 1 | 2015 | 108 | 0.120 |
Why?
|
Baseball | 1 | 2015 | 90 | 0.120 |
Why?
|
Health Priorities | 1 | 2017 | 380 | 0.120 |
Why?
|
Osteomyelitis | 1 | 2018 | 402 | 0.120 |
Why?
|
Thoracic Vertebrae | 2 | 2016 | 608 | 0.120 |
Why?
|
Hypopituitarism | 1 | 2016 | 254 | 0.120 |
Why?
|
Hospitals | 2 | 2020 | 3952 | 0.120 |
Why?
|
Head Protective Devices | 1 | 2015 | 114 | 0.120 |
Why?
|
Cerebrum | 1 | 2015 | 137 | 0.120 |
Why?
|
Income | 1 | 2023 | 1913 | 0.120 |
Why?
|
Conflict of Interest | 1 | 2019 | 543 | 0.120 |
Why?
|
Seizures | 3 | 2021 | 2859 | 0.120 |
Why?
|
Age Factors | 7 | 2021 | 18367 | 0.120 |
Why?
|
Prolactin | 3 | 2023 | 669 | 0.120 |
Why?
|
Cerebral Hemorrhage | 3 | 2023 | 2647 | 0.120 |
Why?
|
Wounds, Nonpenetrating | 1 | 2020 | 794 | 0.120 |
Why?
|
Fertility | 1 | 2018 | 780 | 0.120 |
Why?
|
Clinical Laboratory Techniques | 1 | 2019 | 738 | 0.110 |
Why?
|
Anesthetics, Intravenous | 1 | 2017 | 417 | 0.110 |
Why?
|
Spinal Cord Injuries | 1 | 2021 | 931 | 0.110 |
Why?
|
Diagnosis, Differential | 3 | 2017 | 12961 | 0.110 |
Why?
|
Medical Records Systems, Computerized | 1 | 2020 | 1204 | 0.110 |
Why?
|
Wakefulness | 2 | 2022 | 1245 | 0.110 |
Why?
|
Longevity | 1 | 2021 | 1069 | 0.110 |
Why?
|
Vena Cava Filters | 2 | 2015 | 252 | 0.110 |
Why?
|
Child | 11 | 2023 | 77679 | 0.110 |
Why?
|
Serum Albumin | 1 | 2016 | 676 | 0.110 |
Why?
|
Geriatric Assessment | 1 | 2020 | 1372 | 0.110 |
Why?
|
Mucus | 1 | 2014 | 321 | 0.110 |
Why?
|
Hydrocortisone | 1 | 2021 | 1826 | 0.110 |
Why?
|
Risk Assessment | 7 | 2020 | 23337 | 0.110 |
Why?
|
Pneumonia, Bacterial | 1 | 2015 | 316 | 0.110 |
Why?
|
Extremities | 1 | 2018 | 865 | 0.110 |
Why?
|
Photosensitizing Agents | 1 | 2016 | 602 | 0.110 |
Why?
|
Neurology | 2 | 2018 | 764 | 0.110 |
Why?
|
Social Behavior | 1 | 2019 | 1127 | 0.100 |
Why?
|
Acromegaly | 1 | 2015 | 347 | 0.100 |
Why?
|
Patient Education as Topic | 2 | 2019 | 2277 | 0.100 |
Why?
|
Cerebral Infarction | 1 | 2017 | 1010 | 0.100 |
Why?
|
Cross-Cultural Comparison | 1 | 2015 | 651 | 0.100 |
Why?
|
Embolism, Paradoxical | 1 | 2012 | 58 | 0.100 |
Why?
|
Decision Support Techniques | 3 | 2017 | 1955 | 0.100 |
Why?
|
Alcohol Drinking | 2 | 2022 | 3966 | 0.100 |
Why?
|
Cross-Over Studies | 1 | 2017 | 2032 | 0.100 |
Why?
|
Spinal Cord Neoplasms | 1 | 2014 | 281 | 0.100 |
Why?
|
International Classification of Diseases | 1 | 2017 | 867 | 0.100 |
Why?
|
Suction | 1 | 2013 | 267 | 0.100 |
Why?
|
Medical Informatics | 1 | 2019 | 743 | 0.100 |
Why?
|
Neoplasm Invasiveness | 1 | 2020 | 3614 | 0.100 |
Why?
|
Polyradiculopathy | 1 | 2011 | 24 | 0.100 |
Why?
|
Imaging, Three-Dimensional | 2 | 2015 | 4044 | 0.100 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2014 | 475 | 0.100 |
Why?
|
Radiotherapy | 1 | 2018 | 1525 | 0.100 |
Why?
|
Depression | 1 | 2011 | 7767 | 0.100 |
Why?
|
South Africa | 1 | 2016 | 1731 | 0.100 |
Why?
|
Cost-Benefit Analysis | 2 | 2020 | 5396 | 0.090 |
Why?
|
Developing Countries | 1 | 2023 | 2814 | 0.090 |
Why?
|
Prevalence | 6 | 2023 | 15226 | 0.090 |
Why?
|
Pregnancy Outcome | 1 | 2021 | 2796 | 0.090 |
Why?
|
Insurance, Health | 2 | 2020 | 2494 | 0.090 |
Why?
|
Immunotherapy, Adoptive | 1 | 2019 | 1269 | 0.090 |
Why?
|
Tumor Suppressor Proteins | 1 | 2020 | 2848 | 0.090 |
Why?
|
Intraoperative Complications | 1 | 2017 | 1195 | 0.090 |
Why?
|
Sex Characteristics | 1 | 2020 | 2586 | 0.090 |
Why?
|
Vision Disorders | 1 | 2017 | 1059 | 0.090 |
Why?
|
Proportional Hazards Models | 4 | 2017 | 12355 | 0.090 |
Why?
|
Exercise | 2 | 2023 | 5615 | 0.090 |
Why?
|
Data Collection | 1 | 2019 | 3340 | 0.090 |
Why?
|
Troponin | 1 | 2013 | 524 | 0.090 |
Why?
|
Glasgow Coma Scale | 2 | 2021 | 570 | 0.090 |
Why?
|
Streptococcus pneumoniae | 1 | 2015 | 714 | 0.090 |
Why?
|
Promoter Regions, Genetic | 1 | 2021 | 5867 | 0.090 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2020 | 11493 | 0.090 |
Why?
|
Causality | 1 | 2016 | 1275 | 0.080 |
Why?
|
Delirium | 1 | 2020 | 1609 | 0.080 |
Why?
|
Biopsy | 1 | 2021 | 6757 | 0.080 |
Why?
|
Spinal Cord | 1 | 2017 | 1809 | 0.080 |
Why?
|
Insurance Coverage | 1 | 2020 | 1901 | 0.080 |
Why?
|
Socioeconomic Factors | 2 | 2020 | 7784 | 0.080 |
Why?
|
Medical Oncology | 2 | 2018 | 2265 | 0.080 |
Why?
|
Public Health | 1 | 2022 | 2603 | 0.080 |
Why?
|
Fluorescent Dyes | 1 | 2016 | 1917 | 0.080 |
Why?
|
Posture | 1 | 2013 | 958 | 0.080 |
Why?
|
Pelvis | 1 | 2013 | 729 | 0.080 |
Why?
|
Hospital Mortality | 3 | 2019 | 5316 | 0.080 |
Why?
|
Piperidines | 1 | 2017 | 1605 | 0.080 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2021 | 3328 | 0.080 |
Why?
|
Checklist | 1 | 2015 | 830 | 0.080 |
Why?
|
Hematoma | 3 | 2018 | 758 | 0.080 |
Why?
|
Galactorrhea | 2 | 2018 | 24 | 0.080 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2018 | 2041 | 0.080 |
Why?
|
Anti-Inflammatory Agents | 1 | 2018 | 1789 | 0.080 |
Why?
|
Breast Neoplasms | 3 | 2020 | 20817 | 0.080 |
Why?
|
Neural Stem Cells | 1 | 2015 | 850 | 0.080 |
Why?
|
Thrombocytopenia | 1 | 2016 | 1175 | 0.080 |
Why?
|
Fluoroscopy | 1 | 2012 | 924 | 0.080 |
Why?
|
Reproducibility of Results | 4 | 2021 | 19907 | 0.080 |
Why?
|
Stem Cell Transplantation | 1 | 2016 | 1620 | 0.080 |
Why?
|
Sensitivity and Specificity | 3 | 2021 | 14726 | 0.080 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2020 | 3068 | 0.080 |
Why?
|
Health Status Disparities | 1 | 2019 | 1797 | 0.080 |
Why?
|
Dementia | 1 | 2021 | 2518 | 0.070 |
Why?
|
Head | 1 | 2013 | 880 | 0.070 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 2279 | 0.070 |
Why?
|
Tomography, X-Ray Computed | 4 | 2019 | 20123 | 0.070 |
Why?
|
Prosthesis Implantation | 1 | 2012 | 642 | 0.070 |
Why?
|
Memory | 1 | 2017 | 2174 | 0.070 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2022 | 3256 | 0.070 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2013 | 1518 | 0.070 |
Why?
|
Surgical Flaps | 1 | 2015 | 1640 | 0.070 |
Why?
|
Bone Neoplasms | 1 | 2018 | 2525 | 0.070 |
Why?
|
Cross Infection | 1 | 2015 | 1416 | 0.070 |
Why?
|
Attention | 1 | 2017 | 2399 | 0.070 |
Why?
|
Pediatrics | 1 | 2021 | 3469 | 0.070 |
Why?
|
Health Care Reform | 1 | 2015 | 1261 | 0.070 |
Why?
|
Area Under Curve | 2 | 2022 | 1655 | 0.070 |
Why?
|
Osteoma | 1 | 2005 | 12 | 0.070 |
Why?
|
Europe | 2 | 2023 | 3339 | 0.070 |
Why?
|
Receptor, erbB-2 | 3 | 2020 | 2416 | 0.070 |
Why?
|
Papilloma, Inverted | 1 | 2005 | 16 | 0.070 |
Why?
|
Blood Loss, Surgical | 2 | 2020 | 661 | 0.070 |
Why?
|
Adrenal Cortex Hormones | 1 | 2014 | 1854 | 0.070 |
Why?
|
Preoperative Period | 2 | 2019 | 548 | 0.070 |
Why?
|
Opioid-Related Disorders | 1 | 2020 | 2065 | 0.070 |
Why?
|
Aspirin | 1 | 2017 | 3282 | 0.060 |
Why?
|
Analysis of Variance | 1 | 2014 | 6367 | 0.060 |
Why?
|
Dura Mater | 2 | 2020 | 291 | 0.060 |
Why?
|
Esthesioneuroblastoma, Olfactory | 1 | 2005 | 56 | 0.060 |
Why?
|
Hemangiopericytoma | 1 | 2005 | 77 | 0.060 |
Why?
|
Platelet Count | 2 | 2019 | 781 | 0.060 |
Why?
|
Sex Factors | 2 | 2015 | 10396 | 0.060 |
Why?
|
Disabled Persons | 1 | 2014 | 1212 | 0.060 |
Why?
|
Bone Screws | 2 | 2020 | 520 | 0.060 |
Why?
|
Skin | 1 | 2018 | 4363 | 0.060 |
Why?
|
Angiofibroma | 1 | 2005 | 68 | 0.060 |
Why?
|
Disease Progression | 1 | 2021 | 13280 | 0.060 |
Why?
|
Placebo Effect | 1 | 2008 | 502 | 0.060 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2020 | 8426 | 0.060 |
Why?
|
Pregnancy | 3 | 2021 | 29142 | 0.060 |
Why?
|
Hemorrhage | 1 | 2015 | 3461 | 0.060 |
Why?
|
World Health Organization | 2 | 2020 | 1318 | 0.060 |
Why?
|
Internet | 1 | 2016 | 3063 | 0.060 |
Why?
|
Thiophenes | 1 | 2008 | 589 | 0.060 |
Why?
|
History, 20th Century | 3 | 2015 | 2739 | 0.060 |
Why?
|
Brain Injuries | 1 | 2015 | 2025 | 0.060 |
Why?
|
Obesity, Morbid | 1 | 2014 | 1213 | 0.050 |
Why?
|
History, 19th Century | 2 | 2015 | 720 | 0.050 |
Why?
|
Carcinoma, Adenoid Cystic | 1 | 2005 | 252 | 0.050 |
Why?
|
Wounds and Injuries | 1 | 2015 | 2400 | 0.050 |
Why?
|
Retreatment | 1 | 2024 | 610 | 0.050 |
Why?
|
Clinical Protocols | 1 | 2008 | 1462 | 0.050 |
Why?
|
Paranasal Sinus Diseases | 1 | 2002 | 116 | 0.050 |
Why?
|
Cell Proliferation | 1 | 2017 | 10480 | 0.050 |
Why?
|
Brain | 3 | 2019 | 26413 | 0.050 |
Why?
|
Case-Control Studies | 4 | 2022 | 21752 | 0.050 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2020 | 5221 | 0.050 |
Why?
|
Intensive Care Units | 1 | 2014 | 3680 | 0.050 |
Why?
|
Phenotype | 1 | 2019 | 16365 | 0.050 |
Why?
|
Vertigo | 1 | 2022 | 202 | 0.050 |
Why?
|
Fatigue | 1 | 2008 | 1531 | 0.050 |
Why?
|
Lithuania | 1 | 2019 | 13 | 0.050 |
Why?
|
Pseudarthrosis | 1 | 2020 | 59 | 0.040 |
Why?
|
Facial Nerve | 1 | 2022 | 271 | 0.040 |
Why?
|
Ultrasonography, Doppler | 1 | 2022 | 458 | 0.040 |
Why?
|
Child, Preschool | 5 | 2021 | 40992 | 0.040 |
Why?
|
Lumbosacral Region | 1 | 2021 | 310 | 0.040 |
Why?
|
Dizziness | 1 | 2022 | 251 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2017 | 7281 | 0.040 |
Why?
|
Contraceptives, Oral | 1 | 2022 | 563 | 0.040 |
Why?
|
Gold | 1 | 2023 | 484 | 0.040 |
Why?
|
Clinical Trials as Topic | 2 | 2021 | 7908 | 0.040 |
Why?
|
Time | 1 | 2020 | 541 | 0.040 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2021 | 648 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2022 | 13668 | 0.040 |
Why?
|
Lung Neoplasms | 2 | 2020 | 13096 | 0.040 |
Why?
|
Intraoperative Period | 1 | 2019 | 520 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2023 | 1677 | 0.040 |
Why?
|
Partial Thromboplastin Time | 1 | 2019 | 206 | 0.040 |
Why?
|
Injury Severity Score | 1 | 2021 | 1013 | 0.040 |
Why?
|
Perioperative Period | 1 | 2019 | 256 | 0.040 |
Why?
|
Herpes Simplex | 1 | 2021 | 470 | 0.040 |
Why?
|
Eustachian Tube | 1 | 2018 | 91 | 0.040 |
Why?
|
Hematocrit | 1 | 2019 | 636 | 0.040 |
Why?
|
International Normalized Ratio | 1 | 2019 | 367 | 0.040 |
Why?
|
Automation | 1 | 2020 | 584 | 0.040 |
Why?
|
Hypophysectomy | 1 | 2016 | 113 | 0.040 |
Why?
|
Rupture, Spontaneous | 1 | 2017 | 354 | 0.040 |
Why?
|
Ownership | 1 | 2019 | 332 | 0.040 |
Why?
|
Quality-Adjusted Life Years | 1 | 2023 | 1683 | 0.040 |
Why?
|
Mortality | 2 | 2018 | 2864 | 0.040 |
Why?
|
Methicillin Resistance | 1 | 2017 | 198 | 0.040 |
Why?
|
Hospital Bed Capacity | 1 | 2017 | 214 | 0.030 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2018 | 339 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 2017 | 25043 | 0.030 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2020 | 602 | 0.030 |
Why?
|
Frail Elderly | 1 | 2020 | 693 | 0.030 |
Why?
|
Discriminant Analysis | 1 | 2016 | 235 | 0.030 |
Why?
|
Mental Disorders | 1 | 2015 | 6601 | 0.030 |
Why?
|
Head Injuries, Penetrating | 1 | 2015 | 28 | 0.030 |
Why?
|
Hospital Charges | 1 | 2017 | 362 | 0.030 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2015 | 4033 | 0.030 |
Why?
|
Propensity Score | 1 | 2022 | 1781 | 0.030 |
Why?
|
Linear Models | 2 | 2017 | 5953 | 0.030 |
Why?
|
Chromosome Deletion | 1 | 2020 | 1401 | 0.030 |
Why?
|
Cutaneous Fistula | 1 | 2015 | 78 | 0.030 |
Why?
|
Leukocyte Count | 1 | 2019 | 1584 | 0.030 |
Why?
|
Hemangioblastoma | 1 | 2015 | 70 | 0.030 |
Why?
|
Amenorrhea | 1 | 2018 | 485 | 0.030 |
Why?
|
Alberta | 1 | 2014 | 64 | 0.030 |
Why?
|
Epidural Abscess | 1 | 2015 | 84 | 0.030 |
Why?
|
Health Status | 2 | 2019 | 4034 | 0.030 |
Why?
|
South Carolina | 1 | 2014 | 99 | 0.030 |
Why?
|
Oregon | 1 | 2014 | 140 | 0.030 |
Why?
|
Drug Monitoring | 1 | 2020 | 956 | 0.030 |
Why?
|
Receptors, Progesterone | 1 | 2019 | 1097 | 0.030 |
Why?
|
Follicle Stimulating Hormone | 1 | 2016 | 739 | 0.030 |
Why?
|
Boston | 2 | 2018 | 9311 | 0.030 |
Why?
|
Perioperative Care | 1 | 2021 | 1000 | 0.030 |
Why?
|
Longitudinal Studies | 3 | 2017 | 13990 | 0.030 |
Why?
|
Patient Satisfaction | 2 | 2017 | 3395 | 0.030 |
Why?
|
Menopause | 1 | 2022 | 1626 | 0.030 |
Why?
|
Vancomycin | 1 | 2017 | 501 | 0.030 |
Why?
|
Twins, Monozygotic | 1 | 2015 | 458 | 0.030 |
Why?
|
Brain Stem Neoplasms | 1 | 2015 | 204 | 0.030 |
Why?
|
Nervous System Malformations | 1 | 2015 | 247 | 0.030 |
Why?
|
Emergencies | 1 | 2019 | 1170 | 0.030 |
Why?
|
Disclosure | 1 | 2019 | 736 | 0.030 |
Why?
|
Infant | 3 | 2021 | 35129 | 0.030 |
Why?
|
Blood Coagulation | 1 | 2018 | 1127 | 0.030 |
Why?
|
Prostheses and Implants | 1 | 2020 | 1387 | 0.030 |
Why?
|
Blood Transfusion | 1 | 2019 | 1296 | 0.030 |
Why?
|
Homicide | 1 | 2015 | 287 | 0.030 |
Why?
|
Carotid Stenosis | 1 | 2019 | 854 | 0.030 |
Why?
|
Chromosome Aberrations | 1 | 2019 | 1814 | 0.030 |
Why?
|
Patient Care | 1 | 2018 | 640 | 0.030 |
Why?
|
Salvage Therapy | 1 | 2018 | 1275 | 0.030 |
Why?
|
Chicago | 1 | 2012 | 240 | 0.030 |
Why?
|
Reference Values | 1 | 2019 | 4982 | 0.030 |
Why?
|
Syndrome | 1 | 2018 | 3250 | 0.030 |
Why?
|
Diagnostic Errors | 1 | 2019 | 1255 | 0.020 |
Why?
|
Epidemiologic Methods | 1 | 2016 | 1365 | 0.020 |
Why?
|
ROC Curve | 1 | 2019 | 3527 | 0.020 |
Why?
|
Aftercare | 1 | 2017 | 866 | 0.020 |
Why?
|
Urban Population | 1 | 2019 | 2021 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2019 | 4929 | 0.020 |
Why?
|
Sacrum | 1 | 2013 | 288 | 0.020 |
Why?
|
Neck | 1 | 2015 | 696 | 0.020 |
Why?
|
Receptors, Estrogen | 1 | 2019 | 2186 | 0.020 |
Why?
|
Administration, Oral | 1 | 2018 | 3913 | 0.020 |
Why?
|
Cerebellar Neoplasms | 1 | 2015 | 587 | 0.020 |
Why?
|
California | 1 | 2014 | 1402 | 0.020 |
Why?
|
Thromboembolism | 1 | 2016 | 985 | 0.020 |
Why?
|
Rabbits | 1 | 2016 | 4892 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2016 | 2970 | 0.020 |
Why?
|
Consensus | 1 | 2019 | 2958 | 0.020 |
Why?
|
Drainage | 1 | 2015 | 1141 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2020 | 4841 | 0.020 |
Why?
|
Health Personnel | 1 | 2023 | 3216 | 0.020 |
Why?
|
Risk Adjustment | 1 | 2013 | 594 | 0.020 |
Why?
|
Wounds, Gunshot | 1 | 2015 | 563 | 0.020 |
Why?
|
Circadian Rhythm | 1 | 2021 | 2624 | 0.020 |
Why?
|
Staphylococcus aureus | 1 | 2017 | 1451 | 0.020 |
Why?
|
Rural Population | 1 | 2019 | 2210 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2016 | 2715 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2021 | 6991 | 0.020 |
Why?
|
Social Class | 1 | 2017 | 1999 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2020 | 2727 | 0.020 |
Why?
|
Postural Balance | 1 | 2013 | 620 | 0.020 |
Why?
|
Staphylococcal Infections | 1 | 2017 | 1400 | 0.020 |
Why?
|
Cardiovascular Diseases | 1 | 2013 | 15161 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2020 | 3646 | 0.020 |
Why?
|
Adenocarcinoma | 1 | 2005 | 6352 | 0.020 |
Why?
|
Program Evaluation | 1 | 2016 | 2486 | 0.020 |
Why?
|
Quality Indicators, Health Care | 1 | 2017 | 1831 | 0.020 |
Why?
|
Medicaid | 1 | 2020 | 2736 | 0.020 |
Why?
|
Adrenergic Uptake Inhibitors | 1 | 2008 | 189 | 0.020 |
Why?
|
Benchmarking | 1 | 2013 | 1042 | 0.020 |
Why?
|
Patient Compliance | 1 | 2017 | 2684 | 0.020 |
Why?
|
Disability Evaluation | 1 | 2014 | 1828 | 0.020 |
Why?
|
Databases as Topic | 1 | 2008 | 475 | 0.020 |
Why?
|
Societies, Medical | 1 | 2018 | 3741 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2012 | 3509 | 0.020 |
Why?
|
Acute Disease | 1 | 2016 | 7148 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2016 | 6485 | 0.020 |
Why?
|
Overweight | 1 | 2016 | 2370 | 0.020 |
Why?
|
Anesthesia | 1 | 2015 | 1548 | 0.020 |
Why?
|
Patient Care Team | 1 | 2015 | 2529 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2019 | 11007 | 0.010 |
Why?
|
Computer Simulation | 1 | 2017 | 6196 | 0.010 |
Why?
|
Feeding Behavior | 1 | 2016 | 3188 | 0.010 |
Why?
|
Stem Cells | 1 | 2016 | 3567 | 0.010 |
Why?
|
Recovery of Function | 1 | 2014 | 2925 | 0.010 |
Why?
|
Sphenoid Sinusitis | 1 | 2002 | 9 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2019 | 4252 | 0.010 |
Why?
|
Critical Care | 1 | 2015 | 2644 | 0.010 |
Why?
|
Research Design | 1 | 2018 | 5987 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2019 | 4463 | 0.010 |
Why?
|
Radiography | 1 | 2013 | 7022 | 0.010 |
Why?
|
Analgesics | 1 | 2008 | 1040 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2019 | 5755 | 0.010 |
Why?
|
Electrocardiography | 1 | 2013 | 6442 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 15525 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 2019 | 11728 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2016 | 18027 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2017 | 25618 | 0.010 |
Why?
|
Inflammation | 1 | 2015 | 10634 | 0.010 |
Why?
|
Animals | 2 | 2016 | 168788 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2008 | 12035 | 0.010 |
Why?
|